Borg Pharma Limited - Abbreviated accounts 16.1

Borg Pharma Limited - Abbreviated accounts 16.1


06346407 1.9.14 31.8.15 31.8.15 Company accounts Private Limited Company FY true false true false false true false ordinary 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pure063464072014-08-31063464072015-08-31063464072014-09-012015-08-31063464072013-08-31063464072013-09-012014-08-31063464072014-08-3106346407ns12:England2014-09-012015-08-3106346407ns14:PoundSterling2014-09-012015-08-3106346407ns7:Director12014-09-012015-08-3106346407ns7:OrdinaryShareClass12014-09-012015-08-3106346407ns7:Director22014-09-012015-08-3106346407ns7:Director32014-09-012015-08-3106346407ns7:CompanySecretary2014-09-012015-08-3106346407ns7:RegisteredOffice2014-09-012015-08-3106346407ns7:EntityAccountantsOrAuditors2014-09-012015-08-3106346407ns5:PlantMachinery2014-09-012015-08-3106346407ns5:FixedAssetInvestmentsOtherThanLoans2015-08-3106346407ns5:FixedAssetInvestmentsOtherThanLoans2014-08-3106346407ns7:OrdinaryShareClass12015-08-3106346407ns7:OrdinaryShareClass12014-08-31
REGISTERED NUMBER: 06346407 (England and Wales)










Abbreviated Unaudited Accounts for the Year Ended 31 August 2015

for

Borg Pharma Limited

Borg Pharma Limited (Registered number: 06346407)






Contents of the Abbreviated Accounts
for the Year Ended 31 August 2015




Page

Company Information 1

Abbreviated Balance Sheet 2

Notes to the Abbreviated Accounts 4

Borg Pharma Limited

Company Information
for the Year Ended 31 August 2015







DIRECTORS: P Khiroya
N Nathwani
K Patel





SECRETARY: P Khiroya





REGISTERED OFFICE: Unit 4 Wintonlea
Monument Way West
Woking
Surrey
GU21 5EN





REGISTERED NUMBER: 06346407 (England and Wales)





ACCOUNTANTS: NSO Associates LLP
75 Springfield Road
Chelmsford
Essex
CM2 6JB

Borg Pharma Limited (Registered number: 06346407)

Abbreviated Balance Sheet
31 August 2015

31.8.14 31.8.15
£    £    Notes £    £   
FIXED ASSETS
268,180 Intangible assets 2 190,280
53,074 Tangible assets 3 35,894
3 Investments 4 3
321,257 226,177

CURRENT ASSETS
169,642 Stocks 209,721
750,947 Debtors 583,446
1,185,037 Cash at bank 1,061,325
2,105,626 1,854,492
CREDITORS
1,352,822 Amounts falling due within one year 838,547
752,804 NET CURRENT ASSETS 1,015,945
1,074,061 TOTAL ASSETS LESS CURRENT
LIABILITIES

1,242,122

9,109 PROVISIONS FOR LIABILITIES 6,066
1,064,952 NET ASSETS 1,236,056

CAPITAL AND RESERVES
3 Called up share capital 5 3
1,064,949 Profit and loss account 1,236,053
1,064,952 SHAREHOLDERS' FUNDS 1,236,056

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 August 2015.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 August 2015 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies
Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of
each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections
394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial
statements, so far as applicable to the company.

Borg Pharma Limited (Registered number: 06346407)

Abbreviated Balance Sheet - continued
31 August 2015


The abbreviated accounts have been prepared in accordance with the special provisions of Part 15 of the Companies Act 2006 relating to small companies.


The financial statements were approved by the Board of Directors on 14 April 2016 and were signed on its behalf by:





P Khiroya - Director


Borg Pharma Limited (Registered number: 06346407)

Notes to the Abbreviated Accounts
for the Year Ended 31 August 2015

1. ACCOUNTING POLICIES

Accounting convention
The financial statements have been prepared under the historical cost convention and in accordance with the
Financial Reporting Standard for Smaller Entities (effective April 2008).

Turnover
Turnover represents net invoiced sales of goods, excluding value added tax.

Goodwill
Goodwill, being the amount paid in connection with the acquisition of a business in 2008, is being amortised evenly over its estimated useful life of ten years.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Plant and machinery etc - 50% on cost and 33% on cost

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow
moving items.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance
sheet date.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension
scheme are charged to the profit and loss account in the period to which they relate.

2. INTANGIBLE FIXED ASSETS
Total
£   
COST
At 1 September 2014
and 31 August 2015 779,000
AMORTISATION
At 1 September 2014 510,820
Amortisation for year 77,900
At 31 August 2015 588,720
NET BOOK VALUE

At 31 August 2015 190,280
At 31 August 2014 268,180

Borg Pharma Limited (Registered number: 06346407)

Notes to the Abbreviated Accounts - continued
for the Year Ended 31 August 2015

3. TANGIBLE FIXED ASSETS
Total
£   
COST
At 1 September 2014 163,104
Additions 19,065
At 31 August 2015 182,169
DEPRECIATION
At 1 September 2014 110,030
Charge for year 36,245
At 31 August 2015 146,275
NET BOOK VALUE
At 31 August 2015 35,894
At 31 August 2014 53,074

4. FIXED ASSET INVESTMENTS
Investments
other
than
loans
£   
COST
At 1 September 2014
and 31 August 2015 3
NET BOOK VALUE
At 31 August 2015 3
At 31 August 2014 3

5. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 31.8.15 31.8.14
value: £    £   
3 ordinary £1 3 3